Shares ntawm Biogen Inc (NASDAQ: IB) tau nce ze li ntawm 45% txij li lub Cuaj Hlis lig tab sis CEO Christopher Viehbacher hais tias tseem muaj "ntau yam uas tsis tau kwv yees" ntawm Biogen.
Cov ntsiab lus tseem ceeb los ntawm CEO kev xam phaj nrog CNBC
Viehbacher ntseeg tau tias qhov nyiam ntawm "Lecanemab" thiab "Zuranolone" yuav pab txhawb kev loj hlob yav tom ntej. Tham tag kis no nrog CNBC's Meg Tirrell, nws sau tseg:
Puas yog koj tab tom nrhiav kom tau cov xov xwm ceev, kub-cov lus qhia thiab kev tsom xam kev ua lag luam?
Sau npe rau Invezz cov ntawv xov xwm, hnub no.
“Peb muaj ob yam khoom zoo tshaj plaws los tso tawm. Peb muaj Zuranolone, cov tshuaj tiv thaiv kev nyuaj siab tshiab tshiab. Ib qho ntawm thawj cov tshuaj tiv thaiv kev nyuaj siab tshiab hauv ob peb lub xyoo caum. Yog li, qhov ntawd yog qhov txaus siab heev. Kuv xav tias ob qho tib si ntawm cov khoom no yuav yog qhov tseem ceeb heev. "
Thaum kawg ntawm nws qhov tseeb tshaj tawm lub quarter, Biogen muaj ntau dua $ 5.70 nphom hauv cov nyiaj ntsuab, sib npaug, thiab kev lag luam kev nyab xeeb uas tus Thawj Coj tau hais tias txaus los txhawb kev loj hlob sab nraud.
Tsiv mus tom ntej, nws cia siab tias tus nqi ntawm cov khoom yuav pab txhawb kev loj hlob thiab.
Nws cov tshuaj Alzheimer tau txais kev pom zoo nrawm
Lub lim tiam dhau los, Food and Drug Administration (FDA) tso cai Kev pom zoo nrawm nrawm rau Lecanemab - Cov tshuaj Alzheimer uas Biogen tsim hauv kev koom tes nrog Japanese Eisai Co.
Raws li CEO Viehbacher, CMS tuaj yeem pib muab kev pab them nqi kho mob no nyob rau ib nrab ntawm 2023.
Kuv xav tias, rau ib qib, Alzheimer's yog ib qho kab mob tsis txaus ntseeg thaum kuv hnov, zoo, tej zaum nws yog me ntsis nco. Nws yog ib tug kab mob tuag taus. Thiab qhov no yog thawj zaug peb tau pom cov khoom lag luam uas pom tau tias muaj txiaj ntsig.
Hauv kev sim tshuaj ntsuam xyuas, Lecanemab tau pom tias muaj txiaj ntsig zoo hauv kev ua kom qeeb ntawm kev txawj ntse los ntawm 27% dhau 18 lub hlis raws li Invezz qhia ntawm no. Wall Street tam sim no muaj qhov kev pom zoo "hnyav" qhov ntsuas ntawm biotech khoom.
Tau qhov twg los: https://invezz.com/news/2023/01/09/biogen-ceo-on-growth-prospects/